Dr Dibyendu Banerjee

vidwan id: 220144

Male

Principal Scientist, Department of Cancer Biology
Central Drug Research Institute

0000-0003-4244-9714 Google Scholar Icon

57216943157

Publications

Total Articles 42

Books 0

Proceedings 0

Publications

Scopus

Citations 853

h-index 17

CrossRef

Citations 290

h-index 11

Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Bio

Laboratory studying the differential expression of DNA repair proteins in human cancers. At present, he conducts studies on both cancer cell lines and human patient samples trying to figure out the genes that can be targeted for breast cancer diagnosis, prognosis and treatment. His lab is also studying the role of Autophagy (cells eating themselves) in human cancers and the role of nutrient deprivation and hypoxia in cancer progression and drug resistance. Further, his lab is also interested in

Personal Details

Male
Principal Scientist , Central Drug Research Institute
Department of Cancer Biology, CSIR-Central Drug Research Institute

No Data Found

There is currently nothing to display here.

Principal Scientist Jun 2011 – Present

Central Drug Research Institute | Department of Cancer Biology

Related Profiles

Experts (0)

Organisations (93+)

View All

Dr Bhupendra N Singh

Chief Scientist

Dr Baisakhi Moharana

Senior Scientist

Prof Atul Goel

Chief Scientist

Dr Arun Kumar Trivedi

Senior Principal Scientist

Senior Scientist

Senior Scientist

Principal Scientist

Senior Scientist

Senior Principal Scientist

Dr Amogh Anant Sahasrabuddhe

Senior Principal Scientist

Co-Authors (19)

Dr Aamir Nazir

Central Drug Research Institute

Dr Beena Pillai

CSIR-Institute of Genomics and Integrative Biology

Dr Chinmay K Mukhopadhyay

Jawaharlal Nehru University

Dr Dipak Datta

Central Drug Research Institute

Dr Dipak Kumar Mishra

Central Drug Research Institute

Dr Vivek Vidyadhar Bhosale

Central Drug Research Institute

Dr Gautam Panda

Central Drug Research Institute

Dr G Mukhopadhyay

Jawaharlal Nehru University

Dr Jimut Kanti Ghosh

Central Drug Research Institute

Dr Jiaur R Gayen

Central Drug Research Institute

Dr Kalyan Mitra

Central Drug Research Institute

Dr Mohammad Imran Siddiqi

Central Drug Research Institute

Dr Prabhat Ranjan Mishra

Central Drug Research Institute

Dr Tulika Prasad

Jawaharlal Nehru University

Dr Rabi Sankar Bhatta

Central Drug Research Institute

Dr Rohit Mahar

Hemwati Nandan Bahuguna Garhwal University

Dr Sanjeev Kanojiya

Central Drug Research Institute

Dr Shyamal K Goswami

Jawaharlal Nehru University

Dr Sanjeev Kumar Shukla

Central Drug Research Institute

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Synergy between human DNA ligase I and topoisomerase 1 unveils new therapeutic strategy for the management of colorectal cancer

Open Access

Article

Journal of Biomolecular Structure and Dynamics. Year: 2023.

Authors: Maurya P.;Rawat R.S.;Gupta S.;Krishna S.;Siddiqi M.I.;Sashidhara K.V.;Banerjee D.

10.1080/07391102.2023.2297817

Machine learning and biological evaluation-based identification of a potential MMP-9 inhibitor, effective against ovarian cancer cells SKOV3

Open Access

Article

Journal of Biomolecular Structure and Dynamics. Year: 2023.

Authors: Sinha K.;Parwez S.;MV S.;Yadav A.;Siddiqi M.I.;Banerjee D.

10.1080/07391102.2023.2240416

Correction: Novel Curcumin Monocarbonyl Analogue-Dithiocarbamate hybrid molecules target human DNA ligase I and show improved activity against colon cancer (Medicinal Chemistry Research, (2023), 32, 1, (57-75), 10.1007/s00044-022-02983-y)

Open Access

Erratum

Medicinal Chemistry Research. Year: 2023. Volume: 32 , Issue: 2 , Pages: 389 .

Authors: Singh D.K.;Mandalapu D.;Kumar S.;Maurya P.;Krishna S.;Thakur S.;Pant S.;Siddiqi M.I.;Sharma V.L.;Banerjee D.

10.1007/s00044-022-03007-5

Molecular dissection studies of TAC1, a transcription activator of Candida drug resistance genes of the human pathogenic fungus Candida albicans

Open Access

Article

Frontiers in Microbiology. Year: 2023. Volume: 14 .

Authors: Jain T.;Mishra P.;Kumar S.;Panda G.;Banerjee D.

10.3389/fmicb.2023.994873

Novel Curcumin Monocarbonyl Analogue-Dithiocarbamate hybrid molecules target human DNA ligase I and show improved activity against colon cancer

Open Access

Article

Medicinal Chemistry Research. Year: 2023. Volume: 32 , Issue: 1 , Pages: 57-75 .

Authors: Singh D.K.;Mandalapu D.;Kumar S.;Maurya P.;Krishna S.;Thakur S.;Pant S.;Siddiqi M.I.;Sharma V.L.;Banerjee D.

10.1007/s00044-022-02983-y

Dual targeted 2-Benzylideneindanone pendant hydroxamic acid group exhibits selective HDAC6 inhibition along with tubulin stabilization effect

Open Access

Article

Year: 2023. Volume: 86 .

Authors: Kumar K.;Das R.;Thapa B.;Rakhecha B.;Srivastava S.;Savita K.;Israr M.;Chanda D.;Banerjee D.;Shanker K.;Bawankule D.U.;Santini B.;Di Paolo M.L.;Via L.D.;Passarella D.;Negi A.S.